Open AccessLong‐Term Follow‐up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug‐Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia
Author(s) -
Spreen Marlon I.,
Martens Jasper M.,
Knippenberg Bob,
Dijk Lukas C.,
Vries JeanPaul P. M.,
Vos Jan Albert,
Borst Gert Jan,
Vonken EvertJan P. A.,
Bijlstra Okker D.,
Wever Jan J.,
Statius van Eps Randolph G.,
Mali Willem P. Th. M.,
Overhagen Hendrik
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.004877
Subject(s) - medicine , critical limb ischemia , restenosis , amputation , percutaneous , angioplasty , clinical endpoint , surgery , stent , randomized controlled trial , vascular disease , arterial disease
Clinical outcomes reported after treatment of infrapopliteal lesions with drug-eluting stents (DESs) have been more favorable compared with percutaneous transluminal angioplasty with a bailout bare metal stent (PTA-BMS) through midterm follow-up in patients with critical limb ischemia. In the present study, long-term results of treatment of infrapopliteal lesions with DESs are presented.